CLINICAL_TRIALS
research
· 2026-03-06
Clinical Trial Update: Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients
Summary
Clinical trial update for the SPoRE natural history study of anthrax and an evaluation of AVA-vaccinated recipients. Sponsored by NIAID, with the study currentl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Anthrax, Bacillus Infections | Status: RECRUITING